| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |